Business Context and Reporting Period
This Form 8-K filing by NanoVibronix, Inc. (trading symbol: NAOV) reports a material corporate action dated August 8, 2025. The registrant is a Delaware corporation headquartered in Tyler, Texas, with common stock listed on the Nasdaq Capital Market. The filing details the implementation of a reverse stock split previously approved by stockholders.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company effected a 1-for-10 reverse stock split of its common stock, effective as of 4:05 p.m. (Delaware time) on August 11, 2025.
- Share Count Reduction: The number of outstanding shares decreased from 7,968,868 to approximately 796,887 shares (subject to rounding adjustments).
- Fractional Shares: No fractional shares were issued; any fractional entitlements were rounded up to the next whole number.
- Authorized Shares: The total number of authorized shares remains unchanged at 40,000,000.
- Equity Awards: Proportionate adjustments were made to the exercise prices and share counts for outstanding awards under the 2024 and 2014 Long-Term Incentive Plans.
- Trading Details: Trading on a split-adjusted basis commenced on August 12, 2025, under the symbol "NAOV" with a new CUSIP number (63008J884).
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management outlook, or specific risk factors beyond the standard incorporation by reference to the Certificate of Amendment and the definitive proxy statement filed on June 20, 2025. The primary purpose of the filing is to disclose the execution of the stockholder-approved amendment to the Certificate of Incorporation.
Investor Verification Checklist
- Verify the new CUSIP number (63008J884) for accurate trade settlement.
- Confirm the adjusted share count and exercise prices for any held options or warrants under the 2014 and 2024 Incentive Plans.
- Review the definitive proxy statement (filed June 20, 2025) for the full rationale and terms of the reverse stock split.
- Monitor the Nasdaq Capital Market listing status to ensure continued compliance with minimum bid price requirements.